DB Wealth Management Group’s AstraZeneca AZN Stock Holding History

DB Wealth Management Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$26.7K	Hold	199	–	–	0.02%	210
2023 Q3	$26.9K	Hold	199	–	–	0.02%	199
2023 Q2	$28.4K	Hold	199	–	–	0.02%	197
2023 Q1	$27.6K	Hold	199	–	–	0.02%	198
2022 Q4	$26.9K	Hold	199	–	–	0.02%	198
2022 Q3	$22K	Hold	199	–	–	0.02%	217
2022 Q2	$26K	Hold	199	–	–	0.02%	204
2022 Q1	$26K	Buy	+199	New	+$23.9K	0.02%	226

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

DB Wealth Management Group's AZN Position: Q4 2023 in Review

DB Wealth Management Group held its AstraZeneca (AZN) position steady in Q4 2023 at 199 shares worth $26.7K. The position accounts for 0.02% of the portfolio, ranked #210.

DB Wealth Management Group first reported a position in AZN in Q1 2022 and has held it in 8 quarters since. The position peaked at $28.4K in Q2 2023. 1,130 funds tracked by Wall St. Rank hold AZN as of Q4 2023.

DB Wealth Management Group held 199 shares of AstraZeneca worth $26.7K as of Q4 2023.
DB Wealth Management Group left its AstraZeneca share count unchanged in Q4 2023.
AstraZeneca made up 0.02% of DB Wealth Management Group's portfolio in Q4 2023, its #210 holding.
DB Wealth Management Group first reported a position in AstraZeneca in Q1 2022 and has held it in 8 quarters since.
DB Wealth Management Group's AstraZeneca position peaked at $28.4K in Q2 2023.
1,130 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2023.

Based on DB Wealth Management Group's 13F filing for Q4 2023, filed 9 Jan 2024.